CompoAtlas

Hemp oil gummy

Natural health product licensed in Canada

Licence holder
Scisparc Nutraceuticals Inc.
NPN or DIN-HM
80140882
Status
Active licence
Licence date
12 May 2025
Revision date
Not provided
Form
Bloc
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Cannabis sativa

Source : Cannabis sativa - Graine

Potency : 16.9 % alpha-Linolenic acid

237 mgNot calculated
Linum usitatissimum

Source : Linum usitatissimum - Graine

Potency : 14.3 % Linoleic acid

45 mgNot calculated
Linum usitatissimum

Source : Linum usitatissimum - Graine

Potency : 19.4 % Oleic acid

Not specifiedNot calculated
Vitamine E

Source : Acétate de d-alpha-tocophéryle

4.5 mg ATNot calculated
Vitamine B6

Source : Chlorhydrate de pyridoxine

2 mgNot calculated
Vitamine B12

Source : Méthylcobalamine

20 MicrogrammesNot calculated
Thiamine

Source : Chlorhydrate de thiamine

40 MicrogrammesNot calculated
Niacinamide

Source : Niacinamide

2 mgNot calculated
Linum usitatissimum

Source : Linum usitatissimum - Graine

Potency : 52 % alpha-Linolenic acid

Not specifiedNot calculated

Non-medicinal ingredients

Bêta-carotène, Triglycérides à chaîne moyenne, Lécithine, Extrait de feuille de Stevia Rebaudiana, Cire de Carnauba, Acide citrique, Sucre de canne, Acide ascorbique, Jus de légumes, Agar, Isomaltooligosaccharides, Saveur de fruit naturelle, Sirop de tapioca, Eau, Citrate de trisodium dihydraté, Pectine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years2 Bloc1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of alpha-linolenic acid (ALA) for the maintenance of good health. Source of omega-3 fatty acid for the maintenance of good health. A factor in normal growth and development. A factor in the maintenance of good health. Helps in energy metabolism/(and) tissue formation. Helps to form red blood cells. Helps to maintain/support healthy metabolism. Helps to maintain/support immune function/the immune system. Multi-vitamin supplement. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/Provides an antioxidant that protects the fat in body tissues from oxidation. Supports energy production.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80140882

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Linum usitatissimum
    Read the warning, when it applies and the studies cited

    FLAXSEED - LINUM USITATISSIMUM

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Applies to products providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 July 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line